We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23.4B
AUM Growth
-$645M
Cap. Flow
-$927M
Cap. Flow %
-3.96%
Top 10 Hldgs %
14.43%
Holding
1,543
New
166
Increased
513
Reduced
496
Closed
116

Top Buys

Rank Stock Value
1
F icon
Ford
F
+$134M
2
PRU icon
Prudential Financial
PRU
+$68.1M
3
ETR icon
Entergy
ETR
+$53.9M
4
CIT
CIT Group Inc.
CIT
+$45.3M
5
BFH icon
Bread Financial
BFH
+$38.9M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$107M
2
PPG icon
PPG Industries
PPG
+$92.5M
3
DB icon
Deutsche Bank
DB
+$90M
4
BKNG icon
Booking.com
BKNG
+$75.1M
5
VZ icon
Verizon
VZ
+$66.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.41%
2 Technology 14.89%
3 Financials 13.52%
4 Industrials 10.44%
5 Energy 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRE icon
551
Green Plains
GPRE
$1.04B
$4.46M 0.02%
119,200
+82,600
+226% +$3.3M
DG icon
552
Dollar General
DG
$27.5B
$4.42M 0.02%
72,400
-252
-0.3% -$15.1K
FBIN icon
553
Fortune Brands Innovations
FBIN
$4.77B
$4.41M 0.02%
125,504
TPLM
554
DELISTED
Triangle Petroleum Corporation
TPLM
$4.4M 0.02%
400,000
GMF icon
555
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$421M
$4.39M 0.02%
52,429
CHT icon
556
Chunghwa Telecom
CHT
$35.2B
$4.38M 0.02%
146,114
MAT icon
557
Mattel
MAT
$3.83B
$4.38M 0.02%
142,860
-5,165
-3% -$183K
CLDX icon
558
Celldex Therapeutics
CLDX
$3.02B
$4.37M 0.02%
+22,483
New +$4.9M
IP icon
559
International Paper
IP
$18B
$4.34M 0.02%
95,960
+798
+0.8% +$36.7K
STX icon
560
Seagate
STX
$176B
$4.34M 0.02%
75,700
-51,900
-41% -$3.07M
CSIQ icon
561
Canadian Solar
CSIQ
$831M
$4.29M 0.02%
+120,000
New +$3.89M
RRMS
562
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
$4.29M 0.02%
72,500
-2,500
-3% -$143K
NKTR icon
563
Nektar Therapeutics
NKTR
$2.28B
$4.21M 0.02%
23,254
-150
-0.6% -$28.7K
HY icon
564
Hyster-Yale Materials Handling
HY
$599M
$4.2M 0.02%
58,580
-22,201
-27% -$1.77M
SJM icon
565
J.M. Smucker
SJM
$13B
$4.17M 0.02%
42,138
+20,600
+96% +$2.11M
ALTR
566
DELISTED
Altera Corp
ALTR
$4.15M 0.02%
116,000
+109,700
+1,741% +$3.82M
INFA
567
DELISTED
INFORMATICA CORP
INFA
$4.11M 0.02%
120,000
ADBE icon
568
Adobe
ADBE
$102B
$4.04M 0.02%
58,431
-186,500
-76% -$13.2M
LVS icon
569
Las Vegas Sands
LVS
$26.7B
$4.04M 0.02%
64,911
+57,000
+721% +$3.92M
CHD icon
570
Church & Dwight Co
CHD
$22.4B
$4.03M 0.02%
115,010
+7,746
+7% +$264K
LHO
571
DELISTED
LaSalle Hotel Properties
LHO
$4.03M 0.02%
117,700
-102,300
-47% -$3.66M
ROST icon
572
Ross Stores
ROST
$72.3B
$4.02M 0.02%
106,400
+5,068
+5% +$176K
COHR
573
DELISTED
Coherent Inc
COHR
$3.99M 0.02%
65,000
CBRE icon
574
CBRE Group
CBRE
$40.6B
$3.98M 0.02%
133,807
+20,000
+18% +$629K
MHFI
575
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$3.98M 0.02%
47,070
+2,500
+6% +$206K

Similar funds

Axa's Q3 2014 Portfolio in Review

As of Q3 2014, Axa held 1,543 positions worth $23.4B, down 2.7% from $24B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $927M in Q3 2014, closing 116 positions and reducing 496 holdings. Its most notable exit was Bunge Global, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Axa opened a new position in CYTEC INDS INC worth $21.7M.

  • Axa's largest Q3 2014 buy was CYTEC INDS INC: 458,648 shares worth $21.7M.
  • Axa added most to Ford in Q3 2014, an estimated $134M increase.
  • Axa's biggest Q3 2014 reduction was UnitedHealth, cutting an estimated $107M.
  • Axa fully exited Bunge Global in Q3 2014, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 14% of its $23.4B portfolio in Q3 2014.
  • Axa opened 166 new positions and closed 116 in Q3 2014.
  • Axa's portfolio value fell 2.7% quarter-over-quarter to $23.4B.

Based on Axa's 13F filing for Q3 2014, filed 13 Nov 2014.